There were 1,920 press releases posted in the last 24 hours and 359,048 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image